Qin Yanmei, Li Qiangzi, Fan Lin, Ning Xiao, Wei Xinlei, You Chun
University of Chinese Academy of Sciences, Beijing, China.
In Vitro Synthetic Biology Center, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Adv Biochem Eng Biotechnol. 2023;186:1-27. doi: 10.1007/10_2023_231.
In vitro biotransformation (ivBT) refers to the use of an artificial biological reaction system that employs purified enzymes for the one-pot conversion of low-cost materials into biocommodities such as ethanol, organic acids, and amino acids. Unshackled from cell growth and metabolism, ivBT exhibits distinct advantages compared with metabolic engineering, including but not limited to high engineering flexibility, ease of operation, fast reaction rate, high product yields, and good scalability. These characteristics position ivBT as a promising next-generation biomanufacturing platform. Nevertheless, challenges persist in the enhancement of bulk enzyme preparation methods, the acquisition of enzymes with superior catalytic properties, and the development of sophisticated approaches for pathway design and system optimization. In alignment with the workflow of ivBT development, this chapter presents a systematic introduction to pathway design, enzyme mining and engineering, system construction, and system optimization. The chapter also proffers perspectives on ivBT development.
体外生物转化(ivBT)是指使用一种人工生物反应系统,该系统利用纯化的酶将低成本材料一锅法转化为生物商品,如乙醇、有机酸和氨基酸。不受细胞生长和代谢的限制,与代谢工程相比,ivBT具有明显的优势,包括但不限于高工程灵活性、操作简便、反应速率快、产品产量高和良好的可扩展性。这些特性使ivBT成为一个有前途的下一代生物制造平台。然而,在改进大量酶制备方法、获得具有优异催化性能的酶以及开发复杂的途径设计和系统优化方法方面,挑战依然存在。与ivBT开发的工作流程一致,本章系统介绍了途径设计、酶挖掘与工程、系统构建和系统优化。本章还对ivBT的发展提出了展望。